This is a high-impact, community-focused role central to BridgeBio’s commercial success. The individual will drive the launch of Infigratinib—a first-in-class therapy for achondroplasia—bring deep clinical acumen, urgency, and a passion for partnering with providers and families. The company pioneered a “moneyball for biotech” approach in 2015, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. They build bridges to groundbreaking advancements in rare disease, and develop life-changing medicines for patients with unmet needs as fast as humanly possible. Together they define white space, push boundaries, and empower people to solve problems. They value curiosity and experimentation—including the ethical & thoughtful use of AI to improve clarity, speed, and quality of work.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior